Abstract
Barrett's esophagus (BE) occurs in 5-15% of patients with gastroesophageal reflux disease (GERD). While acid suppressive therapy is a critical component of BE management to minimize the risk of progression to esophageal adenocarcinoma, surgical control of mechanical reflux is sometimes necessary. Magnetic sphincter augmentation (MSA) is an increasingly utilized anti-reflux surgical therapy for GERD. While the use of MSA is listed as a precaution by the United States Food and Drug Administration, there are limited data showing effective BE regression with MSA. MSA offers several advantages in BE including effective reflux control, anti-reflux barrier restoration and reduced hiatal hernia recurrence. However, careful patient selection for MSA is necessary.
Original language | English (US) |
---|---|
Article number | doac096 |
Journal | Diseases of the Esophagus |
Volume | 36 |
DOIs | |
State | Published - Jun 1 2023 |
Keywords
- Barrett's esophagus
- LINX
- anti-reflux surgery
- endoscopic eradication therapy
- magnetic sphincter augmentation
ASJC Scopus subject areas
- General Medicine